THE. HE CLINICAL and laboratory features of Candida meningitis were first described in 1933 by Smith and Sano.1 Since that date, only 25 patients have been reported. Of these, only four have been successfully treated with amphotericin B. The present report represents the fifth successfully treated patient with Candida meningitis further signified by occurring in a patient who was treated for blastic crisis of chronic myelogenous leukemia. Blastic crisis itself occurs in approximately 80% of patients with chronic myelogenous leukemia as a terminal disease.2 Thus, the occurrence of Candida meningitis successfully treated with amphotericin B, in a patient who also had a remission induced from a blastic crisis, is considered an opportune occasion to review the world's literature and summarize the clinical and laboratory findings and to discuss therapeutic results. Report of Case This white housewife (CC 04-28-67) was born June 1, 1896, and in good health until